PT
Pelthos Therapeutics Inc. (PTHS)
AMEX·Healthcare·Biotechnology
$26.59
-4.25%
Mkt Cap $15.45M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$60.50
Range $55.00 – $66.00
Implied Upside
+127.5%
Consensus $60.50 vs current $26.59
AMEX·Healthcare·Biotechnology
$26.59
-4.25%
Mkt Cap $15.45M
No recent rating data.
Price Target (7 analysts)
$60.50
Range $55.00 – $66.00
+127.5%
Consensus $60.50 vs current $26.59